Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 737 of 6351
-
New drug shows promise for fatty liver cirrhosis in early trial
Disease control OngoingResearchers are looking for ways to treat a type of liver disease caused by elevated liver fat, called metabolic dysfunction-associated steatohepatitis (MASH). MASH was formerly called non-alcoholic steatohepatitis (NASH). Researchers want to learn if a study medicine called efin…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Donor vaccine aims to shield transplant patients from common virus
Prevention Recruiting nowThis phase II clinical trial tests how well the cytomegalovirus-modified vaccinica Ankara (CMV-MVA) Triplex vaccine given to human leukocyte antigens (HLA) matched related stem cell donors works to prevent cytomegalovirus (CMV) infection in patients undergoing hematopoietic stem …
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Prevention
Last updated Jun 27, 2026 11:00 UTC
-
Zapping the brain to restore speech after stroke?
Symptom relief Recruiting nowThe goal of this study is to see if transcranial alternating current stimulation (tACS) can be used to enhance language abilities in people with post-stroke aphasia. Participants will receive real and sham tACS in conjunction with various language tests. Researchers will compare …
Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
New antibody could block malaria transmission in High-Risk areas
Disease control CompletedMali faces a significant challenge with malaria, particularly among its younger population. While existing measures like seasonal chemoprevention and vaccination have shown efficacy, further innovations are necessary to combat this disease. The monoclonal antibody TB31F shows pro…
Phase 1/2 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New hope for lung cancer patients with brain tumors: targeted drug T-DXd enters trial
Disease control By invitation only'1. Objective * Primary objective \- Median Intracranial Progression-free survival(icPFS) as defined by RANO(Response Assessment in Neuro-Oncology) criteria * Secondary objective * Progression free survival(PFS) as defined by RECIST 1.1 * Median Intracranial progression …
Phase 2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Could a new drug help kids regrow hair? major trial underway
Disease control Recruiting nowThis is a prospective, randomized, double-blind, placebo-controlled clinical trial. The study will take place at four sites. This trial will enroll a total of 76 children and adolescents with moderate to severe AA (affecting at least 30% of the scalp) at the time of screening wit…
Phase 2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hope for chronic hive sufferers: drug shows promise in major trial
Disease control OngoingThe purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urticaria (CSU) inadequately controlled by non-sedating second generation H1-antihistamines in comparison to placebo.
Phase 3 • Sponsor: Celldex Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New Biomarker-Guided cocktail aims to wipe out esophageal cancer before surgery
Disease control Recruiting nowThis study aims to evaluate the impact of the neoadjuvant treatment strategy based on CPS score on the pathological complete response (pCR) rate in patients with resectable locally advanced esophageal cancer.
Phase 2 • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Jun 26, 2026 17:14 UTC
-
Gene therapy retreatment aims to cut surgeries for rare throat tumor condition
Disease control Recruiting nowThis open-label study evaluates safety, vector shedding, and retreatment efficacy of Zopapogene imadenovec (Zopa) in adults with recurrent respiratory papillomatosis (RRP). Two cohorts will be enrolled (n=30): Cohort 1 to assess the magnitude and duration of adenoviral vector she…
Phase 4 • Sponsor: Precigen, Inc • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New imaging technique may forecast lymphoma treatment response
Knowledge-focused Recruiting nowThis multicenter study aims to evaluate the predictive value of tumor microenvironment PET/CT imaging for treatment response and prognosis in patients with aggressive lymphoma. Eligible patients with histologically confirmed aggressive lymphoma will undergo FAPI PET/CT imaging, a…
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Smart patch and coach app aim to tame diabetes in pregnancy
Disease control Recruiting nowThe ACHIEVE RCT will measure the effect of the intervention (mHealth app with CGM, provider dashboard, and care team coaching) compared to current standard care (prenatal visits, self-monitored blood glucose, and certified diabetes care and education specialist) on achieving glyc…
Sponsor: Ohio State University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Watching patients take medicine: a new way to boost sickle cell treatment?
Disease control CompletedThis study is for caregivers of young children with sickle cell disease and adolescents with sickle cell disease who are currently prescribed hydroxyurea and are receiving care at one of the study sites. The study will assess retention and engagement during a pilot randomized con…
Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New hope: drug may shield kids from virus after transplant
Disease control Recruiting nowThis phase III single arm trial determines whether taking prophylactic letermovir will reduce the likelihood of infection with cytomegalovirus (CMV) in children and adolescents after stem cell transplant compared to estimated rate of infection without prophylaxis. The treatments …
Phase 3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New CAR t-cell combo aims to control aggressive leukemia
Disease control Recruiting nowTo learn about the safety of giving the drug brexucabtagene autoleucel to participants with relapsed/refractory B-cell ALL after treatment with inotuzumab ozogamicin, blinatumomab, and either hyper-CVAD or mini-hyper-CVD. Also, to learn if giving brexucabtagene autoleucel to pati…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New hope for hard-to-treat ovarian cancer: experimental combo enters phase 2 trial
Disease control Recruiting nowTo evaluate the efficacy and safety of B013 in patients with platinum-resistant recurrent ovarian cancer.
Phase 2 • Sponsor: Shanghai Jiaolian Drug Research and Development Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Engineered immune cells take on childhood cancers in early trial
Disease control Recruiting nowThe purpose of this study is to test the manufacturing feasibility and safety of intravenous (IV) administration of B7-H3CART in children and young adult subjects with relapsed and/or refractory solid tumors expressing B7-H3 target using a standard 3+3 dose escalation design.
Phase 1 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New heart valve study aims to improve life for patients with narrowed aortic valve
Disease control Recruiting nowThe study will evaluate the efficacy and safety of transcatheter aortic valve implantation (TAVI) using the Hydra transcatheter aortic heart valve (THV) series, in patients with severe aortic stenosis up to 1-year after the procedure. This will include an evaluation of the preser…
Sponsor: Sahajanand Medical Technologies Limited • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New hope for rare cancers: daratumumab trial targets Hard-to-Treat lymphomas
Disease control Recruiting nowBackground: Primary effusion lymphoma (PEL), plasmablastic lymphoma (PBL), and Multicentric Castleman Disease (MCD) are aggressive forms of cancer that affects cells in the immune system and lymph nodes. How they develop is not well understood, and these diseases do not respond …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New hope for kids with tough cancers: precision drugs tested
Disease control Recruiting nowA companion platform trial to test novel targeted agents based on the patient's tumor profile.
Phase 1/2 • Sponsor: Australian & New Zealand Children's Haematology/Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug combo shows promise in shrinking liver tumors before surgery
Disease control PausedThis phase II trial tests how well giving durvalumab with standard chemotherapy, gemcitabine and cisplatin, before surgery works in treating patients with high risk liver cancer (cholangiocarcinoma) that can be removed by surgery (resectable). Durvalumab is a monoclonal antibody …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC